Lido Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Lido Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $459 - $593	-21 Reduced 0.13%	15,591 $405,000
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $571 - $829	21 Added 0.13%	15,612 $446,000
Q4 2023 Feb 14, 2024	SELL	$21.2 - $31.03 $4,685 - $6,857	-221 Reduced 1.4%	15,591 $477,000
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $8,960 - $12,339	342 Added 2.21%	15,812 $424,000
Q2 2023 Aug 09, 2023	BUY	$25.16 - $41.38 $389,225 - $640,148	15,470 New	15,470 $551,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.